Erbecryo2
Payments companies reported to CMS as associated with Erbecryo2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbecryo2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbecryo2
These are the largest totals companies reported as associated with Erbecryo2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Justin Thomas | Rancho Mirage, CA | Pulmonary Disease | $108.48 |
| Shari Meyerson | Lexington, KY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $100.00 |
| Zachary Fyffe | Lexington, KY | Internal Medicine | $100.00 |
| Mateen Ahmed | Somerset, KY | Pulmonary Disease | $100.00 |
| Kelli Mathew | Lexington, KY | Pulmonary Disease | $100.00 |
| Joseph Mammarappallil | Durham, NC | Diagnostic Radiology | $100.00 |
| Eliseo Colon-Carreras | Lexington, KY | Pulmonary Disease | $100.00 |
| Otis Rickman | Nashville, TN | Pulmonary Disease | $100.00 |
| Imtiaz Hussain | South Williamson, KY | Pulmonary Disease | $100.00 |
| Sandra Schuldheisz | Somerset, KY | $100.00 |
Prescribed Erbecryo2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.